These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

879 related items for PubMed ID: 19664879

  • 1. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK, Joe YA, Lee SK, Kim EK, O E, Kim HK, Oh BJ, Hong SH, Hong YK.
    Cancer Lett; 2010 Feb 28; 288(2):251-60. PubMed ID: 19664879
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 3. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 4. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
    Zhao S, Cai J, Bian H, Gui L, Zhao F.
    Cancer Invest; 2009 Jul 01; 27(6):636-40. PubMed ID: 19387877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):888-96. PubMed ID: 17293239
    [Abstract] [Full Text] [Related]

  • 8. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.
    Clin Cancer Res; 2000 Aug 01; 6(8):3354-60. PubMed ID: 10955823
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L, Yu D, Hicklin DJ, Hannay JA, Ellis LM, Pollock RE.
    Cancer Res; 2002 Apr 01; 62(7):2034-42. PubMed ID: 11929822
    [Abstract] [Full Text] [Related]

  • 11. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 12. Cytosolic and calcium-independent phospholipase A(2) mediate glioma-enhanced proangiogenic activity of brain endothelial cells.
    Giurdanella G, Motta C, Muriana S, Arena V, Anfuso CD, Lupo G, Alberghina M.
    Microvasc Res; 2011 Jan 20; 81(1):1-17. PubMed ID: 21094175
    [Abstract] [Full Text] [Related]

  • 13. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 14. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 16. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
    Liu W, Chen Y, Wang W, Keng P, Finkelstein J, Hu D, Liang L, Guo M, Fenton B, Okunieff P, Ding I.
    Am J Clin Oncol; 2003 Aug 15; 26(4):S103-9. PubMed ID: 12902866
    [Abstract] [Full Text] [Related]

  • 17. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 18. The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth.
    Kim CK, Hong SH, Joe YA, Shim BS, Lee SK, Hong YK.
    Cancer Sci; 2007 Feb 01; 98(2):253-8. PubMed ID: 17233842
    [Abstract] [Full Text] [Related]

  • 19. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH, Li ZR, Zhou X, Ouyang YZ, Zhou ZY, Zeng L.
    Ai Zheng; 2006 Apr 01; 25(4):414-20. PubMed ID: 16613672
    [Abstract] [Full Text] [Related]

  • 20. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.